Oscar Health (OSCR) is accused of misusing the No Surprises Act to delay payments and underpaying California health systems, The Capitol Forum says in a post shared on X.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Cautious Outlook Amid Uncertainty: Sell Rating for Oscar Health
- Oscar Health Faces Uncertainty Amid Revenue Miss and Enrollment Risks, Analyst Maintains Sell Rating
- Oscar Health Shines in 2024 Earnings Call
- Oscar Health wekaness a buyin opportunity, says Baird
- Oscar Health: Buy Rating Backed by Promising 2025 Guidance and Strategic Risk Management